08:00 , Jan 28, 2013 |  BC Week In Review  |  Company News

Algorithme, SQI Diagnostics deal

SQI and Algorithme partnered to develop a multiplex proof-of-concept assay targeted at testing immunogenicity of heparin and heparin-based low molecular weight biosimilar compounds using SQI's Ig Plex multiplexing technology. SQI expects a commercial version...